According to the American Cancer Society, pancreatic cancer is currently the third leading cause of cancer-related deaths in the U.S., and rates are rising faster than any other cancer in the country. Researchers predict it will become the second deadliest cancer in the U.S. by 2030, second only to lung cancer.
Read more on New Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk…
Read More BRCA gene, pancreatic cancer treatment, PARP-I
We hosted a dinner on PARP Inhibitors recently. PARP Inhibitors are a class of medications that may have benefits in Triple Negative and other Breast Cancers in women with a BRCA mutation. Homologous Recombination Deficiencies are associated with several cancers, including breast cancer, and can be identified in breast cancer tissue itself. Tumors with a homologous recombination deficiency (including BRCA mutations) are described as HRD-positive.
Read more on More Hope For PARP Inhibitors In Treating Breast Cancer…
Read More BRCA gene, HRD, PARP-I, Triple Negative Breast Cancer
I recently had a man contact me because he felt a lump near his nipple and was concerned it might be breast cancer. He was smart to be concerned, because men do get breast cancer. Many people don’t realize that men have breast tissue, which means they can develop breast cancer.
Read more on Men Get Breast Cancer Too, And It May Affect Their Children’s Genetic Outlook…
Read More BRCA gene, treating male breast cancer
Joanne was watching Jurassic Park with her son, Tommy. It was his birthday and he wanted to watch an old movie?! Good grief! Joanne watched the screen as Mr. DNA described how the scientists at Jurassic Park had recreated dinosaurs. Then Joanne wondered if Mr. DNA could recreate dinosaurs, could Mr. DNA cure cancer?
Read more on Breast Cancer in the Age of Genetics: Using DNA to Guide Treatment and Reduce Risk…
Read More BRCA gene, DNA, her2-positive breast cancer, oncotypeDX, Ovarian cancer